2007
DOI: 10.1038/nmat1879
|View full text |Cite
|
Sign up to set email alerts
|

Nanomedicine: Industry-wise research

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
21
0
2

Year Published

2007
2007
2015
2015

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 48 publications
(23 citation statements)
references
References 3 publications
0
21
0
2
Order By: Relevance
“…Dual dynamics of promises, and waiting games around emerging nanotechnologies 577 and regulatory processes (Eaton 2007). Not much is happening in practice, also because of uncertainties about intellectual property rights.…”
Section: Constellations In the Waiting Gamementioning
confidence: 99%
“…Dual dynamics of promises, and waiting games around emerging nanotechnologies 577 and regulatory processes (Eaton 2007). Not much is happening in practice, also because of uncertainties about intellectual property rights.…”
Section: Constellations In the Waiting Gamementioning
confidence: 99%
“…Over the past two decades many nanoscale systems have been proposed [8,9]. Nowadays not only nanoparticles but also nanoparticles-based therapeutic products are commercially available [10,11].…”
Section: Introductionmentioning
confidence: 99%
“…Currently, courses of drugs costing more than 10,000 a year are considered too expensive, so the cost of the raw materials must be significantly less 61 . Hence, exotic drug-delivery devices made from synthetic nucleic acid or decorated with highly specific peptides as targeting moieties are unlikely to compete with cheaper materials, unless they offer very significant advantages.…”
Section: Toward Industrial Manufacturing Of Nanomedicinesmentioning
confidence: 99%